[Spastic syndrome and main directions of its treatment].
Damulin
I V
IV
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D003000:Clonidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D016472:Motor Neuron Disease / Q000150:complications / Q000503:physiopathology; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy*; D009129:Muscle Tonus / Q000502:physiology; D026741:Physical Therapy Modalities; D011712:Pyramidal Tracts / Q000473:pathology / Q000503:physiopathology; D013577:Syndrome
D018726:Anti-Dyskinesia Agents; D009125:Muscle Relaxants, Central; C023754:tizanidine; D001905:Botulinum Toxins; D003000:Clonidine